Table 1.
Injury Types |
Protective Mechanism |
Hypothermia (°C) |
Hypothermia Length (Hour) /Condition |
Molecular Effect | Model | Refs. |
---|---|---|---|---|---|---|
HIBI | Anti-apoptotic | 34.9 | 12 post-ischemic |
Reduce apoptotic cell death | Piglets | [44] |
HIBI | Anti-apoptotic | 30 | 72 post-ischemic |
Suppress cytochrome c release and activation of caspase-3 and calpain |
Wistar rat pups |
[46] |
HIBI | Anti-apoptotic | 30 | 10 post-ischemic |
Reduce levels of cytochrome c and activation of caspase-3 and −2 |
Wistar rat pups |
[47] |
HIBI | Anti-apoptotic | 30 | 24 post-ischemic |
Decrease phosphor-Akt and caspase-3 levels, total Akt levels remain unchanged |
Sprague- dawley rat pups |
[50] |
HIBI | Anti-apoptotic | 30–32 | >24 | Reduce caspase-8 and −9 activity, delay caspase-3 activation, inhibit cytochrome c and AIF release, and attenuate markers of oxidation |
PC12 cells | [53] |
TBI | Anti-apoptotic | 32 | 72 /combination with propofol |
Decrease tissue trauma | Organotypic hippocampal brain slices |
[39] |
TBI | Anti-apoptotic | 30.8 | 24 post-injury |
Suppress JNK activation and prevent apoptosis |
Sprague- Dawley rats |
[63] |
TBI | Anti-apoptotic | 32 ± 0.5 | 2 | Decrease calpain activity | Cultured rat neurons |
[65] |
TBI | Anti-apoptotic | 32 | 24, 72 | Decrease the levels of caspase-3 mRNA and immunoreactivity and attenuate TIMP-3 activation |
Sprague- Dawley rats |
[66] |
TBI | Anti-apoptotic | 30 | 0.75/pre-injury 1/post-injury |
Attenuate MAP-2 degradation | Rats | [67] |
HIBI | Anti- inflammatory |
33 | 72 | Reduce levels of IL-6, IL-10, and NO | Neonatal wistar rats Microglia culture |
[54] |
TBI | Anti- inflammatory |
30 | 1.5 | Cold pre-conditioning evoke neuroprotection with the involvement of TNF-α, and IL-11 |
Rat hippocampal slices |
[69] |
TBI | Anti- inflammatory |
35 | 4 post-injury |
The enhancing capability of heat acclimation mice to maintain hypothermia after injury may contribute to the functional benefit of the acclimation process |
Mice | [68] |
TBI | Anti- inflammatory |
33 | 3 | Downregulate inflammatory response genes effects on synapse organization, Biogenesis (upregulated) and regulate the mRNA expression of Ank3, Cmbp, Nrxn3, Tgm2, and Fcgr3 |
Rat hippocampus |
[36] |
TBI | Anti- inflammatory |
32–35 | <24 | Attenuate MMP-9 and IL-6 levels | Human patients |
[70] |
HIBI | Anti-oxidative | 33–34 | 72 | Decrease rise in CRP and slower rise in hydroperoxides |
Term infants | [56] |
TBI | Anti-oxidative | 32–33 | 24 post-ischemia |
Reduce astrocytes and inflammatory cytokine levels |
Sprague dawley |
[55] |
HIBI | Anti-excitation | 34 | 3 | Suppress NMDA receptor phosphorylation and protein oxidation |
Piglets | [57] |
TBI | Anti-excitation | 23, 32 | 0.5, 1 | Attenuate the uptake of extracellular glutamate via hGLT-1 |
Chinese hamster ovary cells |
[40] |
TBI | Anti-excitation | 30 | 24 /after 0.5–1.67 hour of oxygen glucose deprivation |
Reduce the release of glutamate to the bathing medium |
Murine cortical cultures |
[72] |
TBI | Anti-excitation | 35 | 1–3 | Attenuate excitatory damage to hippocampal neurons |
Rats | [73] |
HIBI | Enhance energy metabolism |
33, 35 | 24 | Prolong nucleotide triphosphate/ phosphate pool and reduce the secondary fall in phosphocreatine/inorganic phosphate ratios |
Piglets | [59] |
HIBI | Enhance energy metabolism |
31 | 31 intra-ischemic |
Increase high energy phosphates and glucose levels, decrease lactate levels |
Rat pups | [58] |
TBI | Reduce BBB disruption |
30 or 33 | 1 /alone or combination with FK506 |
Reduce BBB disruption following TBI, significantly enhance vascular and axonal protection, and prevent BBB dysfunction |
Rats | [76] [81] |
TBI | Protect Cerebral Circulation |
32 | 1.5 | Protect cerebral microcirculation | Rats | [80] |
TBI | Anti- brain edema |
23.17 + 0.95 25.19 + 0.76 30.53 + 0.8 30.37 + 0.67 27.33 + 1.13 27.43 + 1.18 |
5 / combination with decompressive craniectomy |
Reduce posttraumatic brain edema | Male CD-1 mice |
[78] |
Explanation of abbreviations can be found in the list of abbreviations.